latest news releases from the newsroom
Elekta's Nomination Committee Appointed
STOCKHOLM, April 7, 2005 (PRIMEZONE) -- In accordance with the decision at the Annual General Meeting on September 21, 2004, the Chairman of the Board of Elekta AB, Mr Akbar Seddigh, today conducted a meeting with representatives for the company's largest shareholders, forming a nomination committee. The committee will develop a proposal for members of the Board to be submitted to the Annual General Meeting for decision as well as prepare other matters for the AGM.
The Pomerantz Firm Charges Bradley Pharmaceuticals, Inc. with Securities Fraud -- BDY
NEW YORK, April 7, 2005 (PRIMEZONE) -- Pomerantz Haudek Block Grossman & Gross LLP (www.pomerantzlaw.com) has filed a class action lawsuit on April 7, 2005 in the United States District Court for the District of New Jersey, against Bradley Pharmaceuticals, Inc. ("Bradley" or the "Company") (NYSE:BDY) and certain of its officers, on behalf of purchasers of the common stock of Bradley during the period from October 8, 2003 to February 25, 2005, inclusive (the "Class Period").
Natural Harmony Food, Inc.
Natural Harmony Foods to Present at Gulf Coast Venture Forum
FORT LAUDERDALE, Fla., April 7, 2005 (PRIMEZONE) -- Natural Harmony Foods, Inc. (Pink Sheets:NHYF), a producer and marketer of unique, natural protein foods, announced today that its CEO and founder, Sam Dewar, has been selected as the featured presenter at an upcoming meeting of the Gulf Coast Venture Forum on Thursday, April 14, in Boca Raton, Florida.
Parker Waichman Alonso LLP
Parker & Waichman, LLP Applauds FDA Decision to Remove Bextra from Market
NEW YORK, April 7, 2005 (PRIMEZONE) -- Parker & Waichman, LLP commends the FDA's decision to remove Bextra from the U.S. market. In 2004, Parker & Waichman, LLP and Seeger Weiss LLP filed the first Bextra heart attack case in the United States. The case was filed in the Supreme Court of the State of New York, County of New York, against Pfizer Inc. (NYSE:PFE). The suit was on behalf of the estate of a 46 year old man who died of a heart attack while using Bextra. The suit claims that Pfizer has not acted responsibly and has failed to adequately warn consumers about the potential side effects associated with Bextra. Parker & Waichman, LLP and Seeger Weiss LLP intend to file additional suits in the coming weeks on behalf of Bextra users who have suffered heart attacks, strokes and serious skin reactions known as Stevens Johnson Syndrome and Toxic Epidermal Necrolysis. Current and former Bextra patients seeking legal help can visit www.bextralegalhelp.com or www.yourlawyer.com/practice/contact.htm?topic=Bextra.
Toll Brothers, Inc.
Toll Brothers Joins Fortune 500
HORSHAM, Pa., April 7, 2005 (PRIMEZONE) -- Toll Brothers, Inc. (NYSE:TOL), (www.tollbrothers.com), the nation's leading builder of luxury homes, today announced its entry into the Fortune 500 of America's Largest Companies. Fortune magazine highlighted Toll Brothers, No. 477 in the group (based on revenues), for its revenue growth of 40% and net income growth of 57.5% in FY 2004 and its 25% average annual growth rate in shareholders' equity since 1994. The Company ranked No. 264 in the Fortune 500 in FY 2004 net income, No. 107 in FY 2004 net profit margin and No. 36 among all companies in ten-year earnings per share growth, producing a 25% compound average annual rate of EPS growth from 1994 to 2004. Within the Fortune 500, the Company's Total Return to Investors ranked No. 27 and No. 20 for FY 2004 and the ten-year period from 1994 to 2004, respectively.
Film & Music Entertainment
World Premiere of Waking Up Dead is Set For Chicago
HOLLYWOOD, April 7, 2005 (PRIMEZONE) -- Film and Music Entertainment, Inc. (Pink Sheets:FLME) in association with Eris Productions and PTP Productions announced today that Waking Up Dead will make its world premiere this week in Chicago. The feature length documentary will be featured at the Chicago International Documentary Festival on Saturday, April 9, 2005.